Skip to main content

Checkpoint Capital L.P.

SEC CIK
0001977548
Latest filing
Aug 14, 2026

ACRS holding history

Aclaris Therapeutics, Inc. in every 13F filed by Checkpoint Capital L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACRS overviewAll 13F holders of ACRSFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2023
Holdings of ACRS by Checkpoint Capital L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−453,614−100.0%Sold outHolders
Q4 2023453,614$476.3K0.3%–No prior filingHolders